Physician profile
Igor Borisov
NPI 1215596705
$4,857.64
in general payments reported to CMS, 2019-2025
11 companies · $4,150 in 2025
The $4,150 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.00 · 2020: $24.22 · 2021: $11.09 · 2022: $261 · 2023: $279 · 2024: $114 · 2025: $4,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $3,750 · Food and Beverage: $769 · Travel and Lodging: $23.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $3,750.00 |
| Food and Beverage | $769.28 |
| Travel and Lodging | $23.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acteon INC | $2,250.00 | 2025 | |
| Sprintray INC | $1,500.00 | 2025 | |
| Biohorizons Implant Systems INC. | $378.85 | 2023-2025 | Biohorizons, Biohorizons Dental Implants |
| Straumann USA LLC | $210.38 | 2022 | |
| Kettenbach LP | $122.16 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $107.39 | 2022-2025 | Arestin, Ossix Plus |
| Zest Holdings, LLC | $95.85 | 2024 | |
| Align Technology, INC. | $90.82 | 2019-2025 | Invisalign |
| Kerr Corporation | $45.55 | 2023 | Access.-Tcm Endo III |
| Nobel Biocare USA | $45.55 | 2023 | Nobelactive |
| Philips North America LLC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Borisov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.